Buy Cancer Medicine from India — WHO-GMP Oncology Drug Exporter

India is one of the world's most important sources of affordable generic cancer medicines. Indian pharmaceutical companies pioneered the production of life-saving oncology generics — particularly targeted therapies like Imatinib (generic Gleevec) — making cancer treatment accessible to millions of patients in low and middle-income countries.

NishJay HealthCare India is a certified oncology drugs supplier from India, offering 53+ cancer medicines from CDSCO-approved, WHO-GMP certified manufacturers.

Why Indian Oncology Generics Matter Globally

The price gap between branded and generic cancer medicines is enormous. Imatinib (Gleevec) branded costs USD 10,000–15,000/month in the USA. Indian generic Imatinib: USD 200–400/month. For patients in developing markets — and increasingly for buyers in USA, UK, and Australia seeking cost reduction — Indian generics are the critical access point.

Key Oncology Products Available from India

Oncology Export Documentation

Cancer medicines require special handling and documentation considerations:

• Controlled substance requirements: Thalidomide and Lenalidomide require REMS (Risk Evaluation and Mitigation Strategy) documentation in the USA
• Cold chain: Some oncology injectables require 2–8°C storage and validated cold-chain shipping
• Import licensing: Many oncology drugs require specific oncology import authorisation in destination countries
• Pricing documentation: Transfer pricing documentation required for regulated market imports

NishJay HealthCare's documentation team prepares complete regulatory packages for oncology product imports including stability data, impurity profiles, and dissolution data as required.

Oncology Products Available for Export